Perioperative management of the dialysis patient
Perioperative assessment · Perioperative & Anaesthesia
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
End-stage renal disease patients on dialysis have altered fluid, electrolyte and drug handling, high cardiovascular risk, anaemia, platelet dysfunction and a precious vascular access to protect. Timing surgery around dialysis and managing potassium are central to safe perioperative care.
Red flags
- Potassium >6.0 mmol/L or ECG changes of hyperkalaemia
- Pulmonary oedema from fluid overload
- Significant perioperative bleeding (uraemic platelet dysfunction)
- Signs of myocardial ischaemia or new arrhythmia
- Compromise of the dialysis access
Assessment
Differential diagnosis
- Hyperkalaemia (missed/inadequate dialysis, tissue breakdown)
- Fluid overload / pulmonary oedema versus hypovolaemia post-dialysis
- Uraemic platelet dysfunction causing bleeding
- Cardiac disease (ischaemia, LVH, pericardial effusion)
- Metabolic acidosis
Investigations
- Urea and electrolytes including potassium immediately before surgery (and after dialysis)
- FBC (anaemia, platelets) and coagulation; group and save (bleeding risk)
- ECG for hyperkalaemia and ischaemia; consider echocardiography if indicated
- Fluid status assessment (weight relative to dry weight, examination)
- Venous/arterial blood gas for acid-base and potassium
Management
- Plan surgery ideally the day after dialysis (euvolaemic, non-heparinised, normal potassium), not immediately after (residual heparin, relative hypovolaemia)
- Check and correct potassium before induction; treat hyperkalaemia if present
- Protect the arteriovenous fistula: no blood pressure cuff, cannula or venepuncture in that limb; pad and document a palpable thrill
- Optimise fluid balance carefully — avoid overload while maintaining perfusion; use dextrose/balanced fluids judiciously and avoid potassium-containing fluids in hyperkalaemia
- Adjust drug choices for renal clearance (avoid accumulating agents and nephrotoxins); prefer atracurium/cisatracurium for neuromuscular blockade
- Maintain cardiovascular stability given high ischaemic risk and consider invasive monitoring for major surgery
- Address uraemic bleeding tendency if excessive oozing (consider desmopressin)
- Plan postoperative dialysis timing and monitor potassium and fluid status
Drugs & doses
Hyperkalaemia — Calcium gluconate 10% 10 mL IV (cardioprotection) plus Insulin 10 units in 25 g glucose IV and Salbutamol 10-20 mg nebulised
Neuromuscular blockade — Atracurium 0.5 mg/kg IV (organ-independent elimination)
Uraemic bleeding — Desmopressin 0.3 microgram/kg IV
Avoid potassium-containing fluids and nephrotoxic NSAIDs; use balanced crystalloid cautiously
Disposition
Stable patients recover on the ward with electrolyte monitoring and planned postoperative dialysis; hyperkalaemia, overload or instability warrants critical-care/renal input.
Complications & pitfalls
- Hyperkalaemic cardiac arrest
- Fluid overload or hypotension from fluid mismanagement
- Bleeding from uraemic platelet dysfunction
- Loss of vascular access
- Cardiac ischaemia/arrhythmia
Exam pearls
- Operate the day after, not the day of, dialysis — fresh dialysis leaves residual heparin and relative hypovolaemia
- Always check potassium before induction and treat hyperkalaemia proactively
- The fistula is the patient's lifeline — no cuffs, cannulae or venepuncture in that arm, and document the thrill
- Use renally safe drugs (atracurium/cisatracurium; avoid long-acting opioids accumulating as morphine-6-glucuronide)
- Suxamethonium is acceptable if potassium is normal, but avoid it with pre-existing hyperkalaemia
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.